ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0801

LncRNA PIGL-217 Regulates Th17 Differentiation by Targeting miR-5008-5p and Suppressing FoxO1 in Behçet’s Disease

Zhimian Wang, Xin Yu, Hua Chen and Wenjie Zheng, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China

Meeting: ACR Convergence 2023

Keywords: Behçet's Syndrome, Micro-RNA, Non-coding RNA, TH17 Cells, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Dysregulated Th17 cells are implicated in Behçet’s disease (BD). However, the underlying mechanism remains unclear. Here we aim to elucidate the mechanism of forkhead box O1 (FoxO1) and its regulating long non-coding RNA (lncRNA) in modulating Th17 cells in BD.

Methods: Th17 cells in peripheral blood mononuclear cells (PBMCs) from BD and healthy controls (HCs) were analyzed by flow cytometry. Naïve CD4+T cells from both groups were isolated for further experiments. Microarray analysis was performed on naïve CD4+T cells of six BD patients and six gender- and age-matched HCs to gain insight into their respective gene expression profiles, which was validated by qRT-PCR analyses. To investigate the role of lncRNA in Th17 differentiation, naïve CD4+T cells were transfected using siRNA, overexpression plasmids or miRNA mimics as required, and were incubated under Th17-polarizing condition for 5 days. A dual-luciferase reporter assay was used to confirm the target of miRNA.

Results: Circulating Th17 cells were elevated in active BD patients (p< 0.0001), which were positively correlated with BDCAF. BD naïve CD4+T cells showed enhanced Th17 cell differentiation capacity compared to HC cells (p< 0.001) (Fig. 1). Microarray analysis revealed that Th17-related FoxO signaling pathway was inhibited in BD naïve CD4+T cells, along with downregulation of FoxO1 and its related lncRNA PIGL-217 (Fig. 2A-B), which was confirmed in vitro (p< 0.0001 and p< 0.001, respectively). We further demonstrated that PIGL-217 silencing in naïve CD4+T cells decreased FoxO1 expression (p< 0.05) and enhanced Th17 differentiation (p< 0.05), which was attenuated by FoxO1 overexpression (p< 0.01) (Fig. 2C). Using competing endogenous RNA (ceRNA) prediction, we identified miR-5008-5p as a candidate gene (Fig. 3A), with increased expression in BD naïve CD4+T cells (p< 0.0001). Dual-Luciferase reporter assay confirmed FoxO1 and PIGL-217 were targeted by miR-5008-5p (Fig. 3B), the expression of which was significantly increased after PIGL-217 knockdown (p< 0.05). Finally, miR-5008-5p mimics significantly down-regulated FoxO1 expression (p< 0.001) and promoted Th17 differentiation (p< 0.01), which was reversed by PIGL-217 overexpression (p< 0.001) (Fig. 3C).

Conclusion: Our data suggest that Th17 cell differentiation is enhanced and plays a role in BD. We identify PIGL-217 as a novel lncRNA regulating Th17 differentiation, which acts as a sponge for miR-5008-5p to regulate FoxO1 expression via the ceRNA mechanism.

Supporting image 1

Fig. 1 Aberrant Th17 cells in BD patients. (A) Level of IL_17A+T cells in peripheral CD4+T cells of HC (n=43), active (n=71) and inactive (n=44) BD patients. (B) Pearson correlation of BDCAF with frequency of circulating IL_17A+T cells. (C) Level of IL_17A+T cells induced from HC (n=23) and BD (n=23) naïve CD4+T cells under Th17-polarizing condition for 5 days. ***p < 0.001, ****p < 0.0001.

Supporting image 2

Fig. 2 Dysregulated PIGL_217 and FoxO1 in BD naïve CD4+T cells. (A) GSEA pathway analysis for differentially expressed mRNAs of BD naïve CD4+T cells. (B) Co-expression network of FoxO1 with associated 25 lncRNAs. (C) Level of Th17 differentiation with PIGL knockdown and FoxO1 overexpression. *p < 0.05, **p < 0.01.

Supporting image 3

Fig. 3 PIGL-miR-5008-5p-FoxO1 ceRNA network. (A) Co-expression network of FoxO1 and PIGL_217 with associated 6 miRNAs. (B) Luciferase reporter activity of PIGL_217 (up) and FoxO1_3′UTR (down) in HEK_293T cells co-transfected with miR-5008-5p mimics or mimics NC. (C) Level of Th17 differentiation transfected with miR-5008-5p mimics alone or co-transfected with FoxO1 overexpression vector. **p < 0.01, ***p < 0.001, ****p < 0.0001.


Disclosures: Z. Wang: None; X. Yu: None; H. Chen: None; W. Zheng: None.

To cite this abstract in AMA style:

Wang Z, Yu X, Chen H, Zheng W. LncRNA PIGL-217 Regulates Th17 Differentiation by Targeting miR-5008-5p and Suppressing FoxO1 in Behçet’s Disease [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/lncrna-pigl-217-regulates-th17-differentiation-by-targeting-mir-5008-5p-and-suppressing-foxo1-in-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lncrna-pigl-217-regulates-th17-differentiation-by-targeting-mir-5008-5p-and-suppressing-foxo1-in-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology